Impairment of Bone Healing by Insulin Receptor Substrate-1 Deficiency
Takashi Shimoaka(Bunkyo University), Hiroshi Kawaguchi(Tokyo Medical Center), Satoru Kamekura(The University of Tokyo), Toru Akune(National Rehabilitation Center for Persons with Disabilities), Wataru Ogawa(Kobe University), Takashi Kadowaki(Toranomon Hospital), Ung‐il Chung(The University of Tokyo), Hirotaka Chikuda(The University of Tokyo), Zenjiro Maruyama(The University of Osaka), Michihiro Matsumoto(Columbia University Irving Medical Center), Yasuo Terauchi(Yokohama City University), Kazuto Hoshi(The University of Tokyo), Kozo Nakamura(Towa Pharmaceutical (Japan)), Toshihisa Komori(Nagasaki University)
Cited by 67
Related Papers
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
Adiponectin and Adiponectin Receptors
|Endocrine Reviews|2005|2.6k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k